NOV vs AROC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 09, 2026

NOV

34.8
AI Score
VS
AROC Wins

AROC

49.7
AI Score

Investment Advisor Scores

NOV

35score
Recommendation
SELL

AROC

50score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric NOV AROC Winner
Revenue 745.00M 2.05B NOV
Net Income 140.51M 19.00M AROC
Gross Margin 47.1% 18.5% AROC
Net Margin 18.9% 0.9% AROC
ROE 9.1% 0.3% AROC
ROA 3.2% 0.2% AROC
Total Assets 4.44B 11.14B NOV
Cash 2.00M 1.34B NOV
Debt/Equity 1.51 0.28 NOV
Current Ratio 1.39 2.47 NOV

Relative Price Performance (Last 90 Days)

NOV 1M: +0.9% · 3M: -0.1% AROC 1M: -1.5% · 3M: -9.1%

Current Technical Phase

NOV

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.5% over 20 days), RSI 54

RSI (14): 53.6 · Price: $21.10

AROC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.0 · Price: $32.77

Fundamentals Snapshot

Metric NOV AROC
Market Cap
Forward P/E 16.7 15.0
Trailing P/E 79.0 17.7
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 0.2% 0.7%
Operating Margin 0.1% 0.4%
EPS 0.27 1.83
Dividend Yield 0.02% 0.03%

Frequently Asked Questions

Based on our detailed analysis, AROC is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.